This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

H. J. TEMPLETON, M.D.; B. M. RIX, M.B.; ROBERT THOMSON, M.D.

Arch Derm Syphilol. 1930;21(5):739-756.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Since its introduction in 1921, by Sazerac and Levaditi, bismuth has rapidly proved its value as an antisyphilitic agent. Many articles have been written attesting to its great worth in patients, and also in animals experimentally infected with syphilis. As in the case of many new remedies some of the early reports have been ultra-enthusiastic. There are at present a number of different salts or compounds of bismuth on the market, so many, in fact, that it is difficult for a physician to evaluate properly the claims made for these various brands and to choose one to use in his practice.

A great deal of work remains to be done in regard to the pharmacology, toxicology and therapeutics of the bismuth preparations. We have attempted to aid in only one phase of this complicated problem, namely, in studying the absorption of the various brands of bismuth by means of roentgen . . . [Full Text PDF of this Article]

Author Affiliations
OAKLAND, CALIF.; PHILADELPHIA; OAKLAND, CALIF.

From the Departments of Dermatology and Syphilology of the Baby Hospital, Oakland, Calif., The Alameda City Health Center, Alameda, Calif., and Fairmont Hospital, Oakland, Calif.

Footnotes
Submitted for publication, Aug. 27, 1929.

Read before the Section on Dermatology and Syphilology at the Eightieth Annual Session of the American Medical Association, Portland, Ore., July 11, 1929.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?